Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.69 | N/A | +0.29% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.69 | N/A | +0.29% |
| Revenue | N/A | N/A | N/A |
Tone: Neutral
Management expressed a commitment to maintaining operational efficiency. They acknowledged current market challenges but did not provide specific guidance.
Management highlighted the importance of ongoing investments in innovation.
They noted that market conditions remain challenging but manageable.
Agilent Technologies reported better-than-expected earnings per share, which indicates some operational strength. However, the stock fell slightly by 0.32%, likely due to the lack of revenue data and forward guidance. Investors may be cautious given the current market conditions mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
CHARLES RIV LABORATO
Feb 13, 2012